Innoviva (INVA) Receivables - Other (2010 - 2022)

Innoviva (INVA) has 16 years of Receivables - Other data on file, last reported at -$2.6 million in Q3 2025.

• Quarterly Receivables - Other rose 71.22% year-over-year to -$2.6 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$10.4 million (down 12.82% YoY) and the FY2024 annual result came in at -$3.6 million, down 124.4% from the prior year.
• Receivables - Other retreated to -$2.6 million in Q3 2025, from $6.1 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $111.7 million in Q2 2022 to a low of -$9.1 million in Q3 2024.
• A 5-year average of $27.9 million and a median of $5.5 million in 2023 frame the typical range for Receivables - Other.
• Annual changes were most pronounced in 2021 — Receivables - Other jumped 2285.85% — and 2024, when it slumped 489.11%.
• Tracing INVA's Receivables - Other over 5 years: stood at $42.5 million in 2021, then plunged by 105.61% to -$2.4 million in 2022, then jumped by 198.16% to $2.3 million in 2023, then tumbled by 489.11% to -$9.1 million in 2024, then surged by 71.22% to -$2.6 million in 2025.
• The last three Receivables - Other figures came in at -$2.6 million (Q3 2025), $6.1 million (Q2 2025), and -$4.7 million (Q1 2025), per Business Quant data.